Canaccord Genuity Group Boosts Privia Health Group (NASDAQ:PRVA) Price Target to $30.00

Privia Health Group (NASDAQ:PRVA - Get Free Report) had its price objective upped by equities researchers at Canaccord Genuity Group from $29.00 to $30.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a "buy" rating on the stock. Canaccord Genuity Group's price objective indicates a potential upside of 17.55% from the stock's current price.

PRVA has been the topic of several other research reports. JPMorgan Chase & Co. lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research note on Friday, November 29th. Truist Financial lifted their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Stephens reiterated an "overweight" rating and issued a $26.00 target price on shares of Privia Health Group in a research report on Thursday, January 2nd. Piper Sandler boosted their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research report on Friday. Finally, Macquarie assumed coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an "outperform" rating and a $25.00 price objective for the company. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Privia Health Group currently has a consensus rating of "Buy" and an average target price of $26.47.

Remove Ads

Privia Health Group Stock Performance

Shares of PRVA traded up $0.56 during mid-day trading on Friday, reaching $25.52. 1,021,318 shares of the company's stock traded hands, compared to its average volume of 752,447. The business's 50-day moving average price is $22.50 and its 200-day moving average price is $20.64. The stock has a market capitalization of $3.06 billion, a P/E ratio of 255.23, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $26.04.

Institutional Investors Weigh In On Privia Health Group

Institutional investors and hedge funds have recently modified their holdings of the stock. First Horizon Advisors Inc. raised its position in shares of Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after purchasing an additional 632 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after purchasing an additional 2,350 shares during the period. Financial Management Professionals Inc. purchased a new position in Privia Health Group in the 4th quarter worth about $51,000. Quarry LP raised its holdings in Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company's stock worth $60,000 after buying an additional 2,533 shares during the period. Finally, KBC Group NV lifted its stake in Privia Health Group by 34.6% during the third quarter. KBC Group NV now owns 3,385 shares of the company's stock valued at $62,000 after buying an additional 871 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.